ResMed Inc. RMD

222.00 0.11 0.05% as of 25 Sep
Market cap
$31.9B
P/E
21.3×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

ResMed Inc. (RMD) P/B ratio

As of 25 September 2026, ResMed Inc. (RMD) trades at a P/B ratio of 4.9×. Over the past ten years it has ranged from 4.1× (June 2026) to 15.0× (September 2021); the current reading is higher than 7% of that period. That is above the Medical Instruments & Supplies industry median of 2.8× and above the Healthcare sector median of 2.5×.

P/B ratio, daily

Annual

Period P/B ratio Change
FY2026 4.3× (32.11%)
FY2025 6.3× 12.25%
FY2024 5.7× (27.23%)
FY2023 7.8× (14.77%)
FY2022 9.1× (26.61%)
FY2021 12.4× 11.85%
FY2020 11.1× 29.85%
FY2019 8.5× 18.78%
FY2018 7.2× 28.14%
FY2017 5.6× 7.33%

Quarterly

Period P/B ratio Change
Jun 2026 4.3× (14.31%)
Mar 2026 5.0× (9.57%)
Dec 2025 5.6× (14.98%)
Sep 2025 6.5× 3.06%
42 more quarters

Against its own ten years

Low 4.1× High 15.0×
Ten-year median 6.8×
Current reading's percentile 7

P/B ratio against peers

Company P/B ratio
COO The Cooper Companies, Inc. compare 1.3×
ALC Alcon compare 1.5×
MDLN Medline Inc. compare 1.6×
BAX Baxter International Inc. compare 2.0×
BDX Becton, Dickinson and Company compare 2.1×
SOLV Solventum Corporation compare 3.2×
RMD ResMed Inc. 4.9×
RGEN Repligen Corporation compare 5.1×
WST West Pharmaceutical Services, Inc. compare 8.8×
Medical Instruments & Supplies industry median 2.8×
Healthcare sector median 2.5×
Market median 1.8×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on RMD